Product Information
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.4785 per GM under NDC 45802081601. Its NADAC has been published 255 times since Mar 11, 2020.
FDA first approved this application on Dec 12, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT
Calcipotriene, Betamethasone DipropionateStrength
.643; 50 mg/g; ug/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802081601
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENEApproval Type
Generic (ANDA)
FDA Application
ANDA200174FDA Approved
12/12/2014
TE Code
AB
On Market Since
1/30/2020
Pharmacological Classes
Price Statistics
The NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT has been published 255 times since Mar 11, 2020, and over the history we have for it it has declined 79.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4785 per GM |
|---|---|
| All-time high | $7.4560 (Sep 16, 2020) |
| All-time low | $1.4785 (Aug 19, 2026) |
| 52-week high | $2.0051 |
| 52-week low | $1.4785 |
| Median price | $3.6345 |
| Average price | $3.5550 |
| Largest weekly change | -37.3% (Sep 23, 2020) |
| Weeks tracked | 255 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.4785 per GM (NDC 45802081601), effective Aug 19, 2026.
How has the price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT changed over time?
Over the history we have for it, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT has declined 79.5%. It has been tracked across 255 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
Since Mar 11, 2020, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT has ranged from a low of $1.4785 (Aug 19, 2026) to a high of $7.4560 (Sep 16, 2020), with a median of $3.6345 per GM.
Are there cheaper alternatives to CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT (NDC 45802081601) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.